(2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol

C13H25NO9 — CID 13076039

IUPAC(2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol
SMILESOCC1=C[C@H](NC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO)[C@H](O)[C@H](O)[C@@H]1O
InChIInChI=1S/C13H25NO9/c15-3-5-1-6(10(20)13(23)9(5)19)14-2-7(17)11(21)12(22)8(18)4-16/h1,6-23H,2-4H2/t6-,7-,8+,9+,10-,11+,12-,13+/m0/s1
InChIKeyBHRLDBKJRVKLRY-BFQKYARKSA-N
MW339.34 g/mol
LogP-5.60
Rot. Bonds8

About (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol

(2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol (PubChem CID 13076039) has the molecular formula C13H25NO9 and a molecular weight of 339.34 g/mol. Its IUPAC name is (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol.

Molecular Properties

Compound Name(2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol
PubChem CID13076039
Molecular FormulaC13H25NO9
Molecular Weight339.34 g/mol
Exact Mass339.15
IUPAC Name(2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol
SMILESOCC1=C[C@H](NC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO)[C@H](O)[C@H](O)[C@@H]1O
InChIInChI=1S/C13H25NO9/c15-3-5-1-6(10(20)13(23)9(5)19)14-2-7(17)11(21)12(22)8(18)4-16/h1,6-23H,2-4H2/t6-,7-,8+,9+,10-,11+,12-,13+/m0/s1
InChIKeyBHRLDBKJRVKLRY-BFQKYARKSA-N
XLogP-5.60
TPSA194.10 Ų
H-Bond Donors10
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms23
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500339.34
LogP ≤ 5-5.60
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol?
The IUPAC name of (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol (CID 13076039) is (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol.
What is the SMILES notation for (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol?
The canonical SMILES for (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol is OCC1=C[C@H](NC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO)[C@H](O)[C@H](O)[C@@H]1O.
What is the InChIKey of (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol?
The InChIKey is BHRLDBKJRVKLRY-BFQKYARKSA-N. The full InChI is InChI=1S/C13H25NO9/c15-3-5-1-6(10(20)13(23)9(5)19)14-2-7(17)11(21)12(22)8(18)4-16/h1,6-23H,2-4H2/t6-,7-,8+,9+,10-,11+,12-,13+/m0/s1.
What are the key properties of (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol?
(2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol has a molecular weight of 339.34 g/mol, XLogP of -5.60, 8 rotatable bonds, 10 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S,4R,5S)-6-[[(1S,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]hexane-1,2,3,4,5-pentol is sourced from PubChem (CID 13076039), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).